Clinical utility of radiomics at baseline rectal MRI to predict complete response of rectal cancer after chemoradiation therapy.
Iva PetkovskaFlorent TixierEduardo J OrtizJennifer S Golia PernickaViktoriya ParoderDavid D BatesNatally HorvatJames FuquaJuliana SchilskyMarc J GollubJulio Garcia-AguilarHarini VeeraraghavanPublished in: Abdominal radiology (New York) (2021)
Combining T2-radiomics and anatomical MRI staging criteria from pre-treatment rectal MRI may help to stratify patients based on the prediction of treatment response to neoadjuvant therapy.